Borgeat, A (2010). Introduction of Rivaroxaban in an Orthopaedic Department. Advances in Orthopaedics, 2(3):100-105.
Rivaroxaban is a new antithrombotic drug that has been shown to provide superior efficacy to enoxaparin without increasing the risk of bleeding after major lower limb surgery. The introduction of this drug in a surgical department represents a paradigm change, since rivaroxaban is not administered preoperatively but postoperatively, and is not given subcutaneously but orally.
Rivaroxaban is a new antithrombotic drug that has been shown to provide superior efficacy to enoxaparin without increasing the risk of bleeding after major lower limb surgery. The introduction of this drug in a surgical department represents a paradigm change, since rivaroxaban is not administered preoperatively but postoperatively, and is not given subcutaneously but orally.
| Item Type: | Journal Article, not_refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Balgrist University Hospital, Swiss Spinal Cord Injury Center |
| Dewey Decimal Classification: | 610 Medicine & health |
| Language: | English |
| Date: | 2010 |
| Deposited On: | 21 Feb 2011 08:19 |
| Last Modified: | 23 Aug 2021 12:35 |
| Publisher: | Remedica Medical Education and Publishing |
| ISSN: | 1758-8294 |
| OA Status: | Closed |
| Related URLs: | http://www.remedicajournals.com/Advances-in-Orthopaedics/Default.aspx (Publisher) |
Borgeat, A